Tetanus
📧 Sign up to get email alerts when something new happens for Tetanus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses [NA]
A completed clinical trial examining how the intestinal microbiome influences immune responses to enteric and systemic vaccines, including r…
-
CLINICAL_TRIALS trial_result · 2017-07-05Clinical Trial Update: Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine [Phase 4]
This Phase 4 clinical trial update reports safety and immunogenicity results of a booster dose of GSK's Boostrix-Polio vaccine; results were…
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine [Phase 2]
Phase 2 trial evaluating the immunogenicity and safety (reactogenicity) of a booster dose of GSK's DTPa-HBV-IPV/Hib vaccine, with results po…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately [Phase 3]
Phase 3 trial compares the immunogenicity and reactogenicity of the hexavalent vaccine DTPa-HBV-IPV/Hib with the separate DTPa-HBV-IPV and H…
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly [Phase 2]
Phase 2 study assessing immunogenicity and safety of DTPa-HBV-IPV/Hib versus DTPa-IPV/Hib with concomitant hepatitis B administration, compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths [Phase 2]
Phase 2 trial evaluating immune response and safety of a DTPw-HBV/Hib booster vaccine given at 15-18 months; study completed.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age [Phase 3]
Phase 3 study evaluating immunogenicity, safety, and tolerability of a fully liquid pentavalent vaccine (DTwP-Hib-HepB) in infants aged 6-8 …
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Tdap Vaccine in Post-Partum Women [Phase 4]
A Phase 4 trial reports results for the Tdap vaccine in postpartum women, assessing protection against diphtheria, tetanus, and pertussis. T…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants [Phase 3]
Phase 3 trial comparing a DTaP-IPV-HepB-PRP-T vaccine with a DTaP-IPV-PRP-T vaccine plus Hep B in Hep B-primed infants has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children. [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of Boostrix Polio as a booster dose in 5- to 6-year-old children; results have been p…
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age [Phase 2]
Phase 2 immunogenicity and safety study of GSK's GSK2202083A vaccine in healthy infants aged 2, 3, and 4 months completed.
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine [Phase 3]
A Phase 3 immunogenicity and safety study evaluating a booster dose of GSK's Poliorix (IPV) and Infanrix+Hib (DTPa/Hib) has completed with r…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers [Phase 2]
Phase 2 trial assessing immunogenicity and reactogenicity of a booster dose of GSK2036874A vaccine in healthy toddlers; study completed with…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose [Phase 2]
Phase 2 immunogenicity and safety study of GlaxoSmithKline's GSK2202083A vaccine given as a booster; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine [Phase 3]
Phase 3 immunogenicity and safety study of GSK's Infanrix-IPV+Hib vaccine completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib) [Phase 3]
Phase 3 safety study of GSK's DTPa-IPV/Hib vaccine (Infanrix-IPV/Hib) has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age. [Phase 2]
Phase 2 feasibility study of GSK's GSK2202083A vaccine in healthy infants at 3, 5, and 11 months was terminated, with results posted in 2017…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination. [Phase 4]
A Phase 4 study evaluated the immunogenicity and safety (reactogenicity) of Boostrix administered 10 years after a prior booster, in individ…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children [Phase 3]
Phase 3 safety study results completed for combination vaccines Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY in child…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease [Phase 4]
Phase 4 trial update on US-licensed combined tetanus, diphtheria, and meningococcal vaccines; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants [Phase 3]
Phase 3 clinical trial update assessing immune memory and reactogenicity of the DTPw-HBV/Hib pentavalent vaccine in infants, including respo…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib. [Phase 3]
Phase 3 trial evaluating safety and immunogenicity of GSK's DTPa/Hib vaccine compared with separate DTPa and Hib administration; the study i…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine [Phase 3]
A Phase 3 study evaluated the safety of two combination vaccines (DTPa-IPV/Hib and DTPa-HBV-IPV/Hib) in infants who had received hepatitis B…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants [Phase 4]
Phase 4 trial updating safety and reactogenicity of DTPa-IPV/Hib vaccine administered at 3, 4, 5 and 18 months in healthy infants; completed…
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Post Marketing Surveillance for ADACEL™ in South Korea [Phase 4]
Phase 4 post-marketing surveillance study for ADACEL™ in South Korea evaluating diphtheria, tetanus, and pertussis in real-world use; study …